Hcg Eko Oncology Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.00 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.00 Cr
About Hcg Eko Oncology Llp
Hcg Eko Oncology Llp (HEOL) is 9 Year, 9 Months old Limited Liability Partnership 15 May 2015. Its registered office is in Bangalore, Karnataka, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.00 M as per MCA.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAD-9508
- Incorporation Date
15 May 2015
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Bangalore
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Hcg Eko Oncology Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Basavalinga Sadasivaiah  | Designated Partner | 01-Mar-2021 | Current |
| Nand Rathore | Designated Partner | 15-May-2015 | Current |
Financial Performance of Hcg Eko Oncology Llp.
Enhance accessibility to Hcg Eko Oncology Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hcg Eko Oncology Llp?
Unlock access to Hcg Eko Oncology Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gha Global Healthcare Academy Private LimitedBasavalinga Sadasivaiah is a mutual person
Bacc Health Care Private LimitedBasavalinga Sadasivaiah is a mutual person
Suchirayu Health Care Solutions LimitedBasavalinga Sadasivaiah is a mutual person
Pashupati Earth Moving Pvt LtdNand Rathore is a mutual person
- Calcutta Medical Imaging Institute Ltd
Nand Rathore is a mutual person
- Eko-Diagnostic Pvt Ltd
Nand Rathore is a mutual person
Charges (Loans)
₹400.00 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 40.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jun 2017 | Yes Bank Limited | ₹40.00 Cr | Open |
How Many Employees Work at Hcg Eko Oncology Llp?
Hcg Eko Oncology Llp has a workforce of 157 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hcg Eko Oncology Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hcg Eko Oncology Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.